Biomatics Capital
  • Portfolio
  • Team
  • News
  • Contact
  • Investor Portal
Select Page

PORTFOLIO NEWS

Verve Therapeutics Appoints Cardiologist Andrew Bellinger, M.D., Ph.D., as CSO

Oct 3, 2019

Aledade Medicare ACOS Improve quality of Care and Health Outcomes

Sep 30, 2019

GRAIL Appoints Marissa Song as General Counsel and Corporate Secretary

Sep 30, 2019

DNA barcoding named Top 10 Emerging Technologies

Sep 25, 2019

Thrive Earlier Detection Announces Appointment of Seema Singh Bhan as Senior VP, Public Policy and External Affairs

Sep 23, 2019

Verve Therapeutics Appoints Drug Delivery Expert Andrew Geall, Ph.D., to Scientific Advisory Board

Sep 16, 2019

AiCure Cofounder Talks Future of Digital in Clinical Trials

Sep 11, 2019

BlackThorn Therapeutics Appoints Healthcare Technology Innovator, Monique Levy, as Chief Strategy Officer

Sep 9, 2019

CRISPR-Chip Moves One Step Closer to the Genomics Market

Sep 6, 2019

The AAO and Verana Health Launch Verana Practice Insights to Innovate Patient Care

Sep 4, 2019

« Older Entries
Next Entries »

PORTFOLIO PRESS COVERAGE

BioWorld: Sanofi taps Denali to help tackle neurodegenerative, inflammatory diseases in $1B-plus collaboration

Nov 2, 2018

FierceBiotech: Ray Tabibiazar departs Aravive to head up development at Twist Bioscience

Oct 28, 2018

Forbes: Milestone Moment: A Parkinson’s Drug Moves Forward With Help From Michael J.Fox

Oct 25, 2018

Hacker Noon: Top 5 Technology advancements

Oct 24, 2018

STAT: Smartphones should fuel the next generation of tuberculosis care

Oct 23, 2018

BioWorld: Startups deploying an expanded toolbox to tackle Alzheimer’s disease

Oct 19, 2018

SF Business Times: Bethesda health tech company Aledade raises $23 million — again

Oct 17, 2018

San Francisco Chronicle: ‘Made-to-order’ DNA firm Twist Bioscience plans to go public

Oct 8, 2018

Modern Healthcare: ACOs reluctant to move to advanced risk-taking models

Oct 6, 2018

FierceBiotech: DDF 2018: How do you fix the glut of immunotherapy combo trials?

Oct 5, 2018

« Older Entries
Next Entries »
© Copyright 2025 Biomatics Capital